Literature DB >> 15128020

Long daily hemodialysis sessions correct systemic complications of oxalosis prior to combined liver-kidney transplantation: case report.

Cándido Díaz1, Fernando Gil Catalinas, Fernando de Alvaro, Alberto Torre, Carmen Sánchez, Olga Costero.   

Abstract

An 18-year-old woman diagnosed with piridoxine-resistent primary hyperoxaluria type 1 (PH-1) and progressive renal insufficiency complicated with acute renal failure of obstructive origin who developed systemic oxalosis affecting the heart (cardiomyopathy), the skin (cutaneous ulcers) and vascular system (lower limb ischemia, as well as pulmonary and cerebral microcirculatory blockage resulting in pulmonary hemorrhage and tonic-clonic general seizures. As conventional hemodialysis (HD) or peritoneal dialysis (PD) are unable to eliminate enough oxalate to avoid a continuous positive balance, long daily sessions (6-7 h) of high-flux hemodialysis (highly permeable polyamide membrane of 2.1 m2) for 67 consecutive days normalized blood oxalate levels and reversed the systemic complications secondary to the calcium oxalate crystals deposit. The patient underwent a combined liver-kidney transplantation and has progressed well to the present time. The most important factors in PH-1 treatment are analyzed. Even though combined liver-kidney transplantation is the treatment of choice and should be performed before the glomerular filtrate rate (GFR) falls below 25 mL/min/1.73 m2, intensive HD becomes necessary to prevent oxalosis in the face of acute renal failure. Also, as our case shows, intensive HD can achieve a negative oxalate balance and reverse both the systemic lesions and the oxalate deposits.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128020     DOI: 10.1111/j.1526-0968.2004.00106.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  2 in total

1.  Oxalate nephropathy associated with chronic pancreatitis.

Authors:  Claire Cartery; Stanislas Faguer; Alexandre Karras; Olivier Cointault; Louis Buscail; Anne Modesto; David Ribes; Lionel Rostaing; Dominique Chauveau; Patrick Giraud
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

2.  Primary hyperoxaluria.

Authors:  Jérôme Harambat; Sonia Fargue; Justine Bacchetta; Cécile Acquaviva; Pierre Cochat
Journal:  Int J Nephrol       Date:  2011-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.